litlas
Log inCreate account

Milton C. Weinstein

Active 1973–2023

149
Papers
39,416
Citations
107
h-index
149
i10-index

Citations

Citations per year for Milton C. Weinstein1977: 1 citations1978: 1 citations1979: 4 citations1980: 9 citations1981: 7 citations1982: 16 citations1983: 12 citations1984: 22 citations1985: 10 citations1986: 30 citations1987: 37 citations1988: 23 citations1989: 41 citations1990: 62 citations1991: 50 citations1992: 56 citations1993: 77 citations1994: 88 citations1995: 99 citations1996: 118 citations1997: 159 citations1998: 142 citations1999: 194 citations2000: 247 citations2001: 232 citations2002: 215 citations2003: 230 citations2004: 238 citations2005: 266 citations2006: 301 citations2007: 271 citations2008: 277 citations2009: 284 citations2010: 289 citations2011: 252 citations2012: 278 citations2013: 215 citations2014: 178 citations2015: 223 citations2016: 219 citations2017: 169 citations2018: 169 citations2019: 675 citations2020: 636 citations2021: 535 citations2022: 365 citations2023: 198 citations2024: 341 citations2025: 145 citations2026: 5 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,219 citing papers, 37.9% of this breakdownUnited Kingdom: 1,100 citing papers, 9.9% of this breakdownCanada: 751 citing papers, 6.8% of this breakdownNetherlands: 494 citing papers, 4.4% of this breakdownAustralia: 419 citing papers, 3.8% of this breakdownChina: 311 citing papers, 2.8% of this breakdownGermany: 304 citing papers, 2.7% of this breakdownSwitzerland: 233 citing papers, 2.1% of this breakdownItaly: 226 citing papers, 2% of this breakdownFrance: 225 citing papers, 2% of this breakdownSpain: 212 citing papers, 1.9% of this breakdownSweden: 198 citing papers, 1.8% of this breakdown
0%37.9%Other 21.9%

Institutions

Fields

  • Medicine61.3%
  • Economics, Econometrics and Finance14.9%
  • Health Professions5.2%
  • Psychology3.3%
  • Biochemistry, Genetics and Molecular Biology2.5%
  • Social Sciences2.2%
  • Other10.6%

Topics

  • Health Systems, Economic Evaluations, Quality of Life6.8%
  • HIV/AIDS Research and Interventions2.3%
  • Healthcare Policy and Management2%
  • Healthcare cost, quality, practices1.8%
  • Global Health Care Issues1.2%
  • Global Cancer Incidence and Screening1.2%
  • Other84.7%

Coauthors

All papers

Open in search
  1. Updating Cost-Effectiveness — The Curious Resilience of the 50,000-per-QALY Threshold

    Authors: Peter J. Neumann, Joshua T. Cohen, Milton C. Weinstein - New England Journal of Medicine 2014 cited by 2,250

  2. Model Parameter Estimation and Uncertainty Analysis

    Authors: Andrew Briggs, Milton C. Weinstein, Elisabeth Fenwick, Jonathan Karnon, Mark Sculpher, A. David Paltiel - Medical Decision Making 2012 cited by 886

  3. Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6

    Authors: Andrew Briggs, Milton C. Weinstein, Elisabeth Fenwick, Jonathan Karnon, Mark Sculpher, A. David Paltiel - Value in Health 2012 cited by 703

  4. QALYs: The Basics

    Authors: Milton C. Weinstein, George W. Torrance, Alistair McGuire - Value in Health 2009 cited by 754

  5. Recommendations of the Panel on Cost-Effectiveness in Health and Medicine

    Authors: Milton C. Weinstein - JAMA 1996 cited by 2,476

  6. Economic Burden of Childhood Autism Spectrum Disorders

    Authors: Tara A. Lavelle, Milton C. Weinstein, Joseph P. Newhouse, Kerim Münir, Karen Kuhlthau, Lisa A. Prosser - PEDIATRICS 2014 cited by 480

  7. Performance of a Five-Item Mental Health Screening Test

    Authors: Donald M. Berwick, Jane M. Murphy, Paula A. Goldman, John E. Ware, Arthur J. Barsky, Milton C. Weinstein - Medical Care 1991 cited by 1,656

  8. Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies

    Authors: Milton C. Weinstein, Bernie J. OʼBrien, John Hornberger, Jeanne Jackson, Magnus Johannesson, Chris McCabe, Bryan R. Luce - Value in Health 2003 cited by 1,178

  9. Probabilistic Sensitivity Analysis Using Monte Carlo Simulation

    Authors: Peter M. Doubilet, Colin B. Begg, Milton C. Weinstein, Peter Braun, Barbara J. McNeil - Medical Decision Making 1985 cited by 851

  10. The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization

    Authors: Michele Kohli, Michael Maschio, Debbie Becker, Milton C. Weinstein - Vaccine 2021 cited by 151

  11. Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States

    Authors: Jaime Rubin, Lisa J. McGarry, David Strutton, Keith P. Klugman, Stephen I. Pelton, Kristen E. Gilmore, Milton C. Weinstein - Vaccine 2010 cited by 105

  12. Foundations of Cost-Effectiveness Analysis for Health and Medical Practices

    Authors: Milton C. Weinstein, William B. Stason - New England Journal of Medicine 1977 cited by 2,140

  13. The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA fall 2023 vaccines in the United States

    Authors: Michele Kohli, Michael Maschio, Keya Joshi, Amy S. Lee, Kelly Fust, Ekkehard Beck, Nicolas Van de Velde, Milton C. Weinstein - Journal of Medical Economics 2023 cited by 27

  14. Does Preventive Care Save Money? Health Economics and the Presidential Candidates

    Authors: Joshua T. Cohen, Peter J. Neumann, Milton C. Weinstein - New England Journal of Medicine 2008 cited by 473

  15. The global cost of nonoptimal blood pressure

    Authors: Thomas A. Gaziano, Asaf Bitton, Shuchi Anand, Milton C. Weinstein - Journal of Hypertension 2009 cited by 307

  16. Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease

    Authors: Ankur Pandya, Stephen Sy, Sylvia Cho, Milton C. Weinstein, Thomas A. Gaziano - JAMA 2015 cited by 257

  17. Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer’s disease

    Authors: Peter J. Neumann, Richard C. Hermann, Karen M. Kuntz, S Araki, Steven B. Duff, José de León, P.A. Berenbaum, Paula A. Goldman, Lawrence Williams, Milton C. Weinstein - Neurology 1999 cited by 244

  18. Impact of Cigarette Smoking and Smoking Cessation on Life Expectancy Among People With HIV: A US-Based Modeling Study

    Authors: Krishna P. Reddy, Robert A. Parker, Elena Losina, Travis P. Baggett, A. David Paltiel, Nancy A. Rigotti, Milton C. Weinstein, Kenneth A. Freedberg, Rochelle P. Walensky - The Journal of Infectious Diseases 2016 cited by 138

  19. The Survival Benefits of AIDS Treatment in the United States

    Authors: Rochelle P. Walensky, A. David Paltiel, Elena Losina, Lauren M. Mercincavage, Bruce R. Schackman, Paul E. Sax, Milton C. Weinstein, Kenneth A. Freedberg - The Journal of Infectious Diseases 2006 cited by 583

  20. Critical ratios and efficient allocation

    Authors: Milton C. Weinstein, Richard Zeckhauser - Journal of Public Economics 1973 cited by 278

  21. Cost-Effectiveness of Computed Tomography Screening for Lung Cancer in the United States

    Authors: Pamela M. McMahon, Chung Yin Kong, Colleen Bouzan, Milton C. Weinstein, Lauren E. Cipriano, Angela C. Tramontano, Bruce E. Johnson, Jane C. Weeks, G. Scott Gazelle - Journal of Thoracic Oncology 2011 cited by 224

  22. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV‐16/18 vaccine

    Authors: Sue J. Goldie, Daniel Grima, Michele Kohli, Thomas C. Wright, Milton C. Weinstein, Eduardo L. Franco - International Journal of Cancer 2003 cited by 214

  23. A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report [7]

    Authors: Louis P. Garrison, Peter J. Neumann, Richard J. Willke, Anirban Basu, Patricia M. Danzon, Jalpa A. Doshi, Michael Drummond, Darius Lakdawalla, Mark V. Pauly, Charles E. Phelps, Scott D. Ramsey, Adrian Towse, Milton C. Weinstein - Value in Health 2018 cited by 154

  24. Cost‐effectiveness of broadly neutralizing antibody prophylaxis for HIV‐exposed infants in sub‐Saharan African settings

    Authors: Caitlin M. Dugdale, Ogochukwu Ufio, Christopher Alba, Sallie R. Permar, Lynda Stranix‐Chibanda, Coleen K. Cunningham, Genevieve G. Fouda, Landon Myer, Milton C. Weinstein, Valériane Leroy, Elizabeth J. McFarland, Kenneth A. Freedberg, Andrea Ciaranello - Journal of the International AIDS Society 2023 cited by 20